Journal profile · Biochemistry, Genetics and Molecular Biology-Biotechnology
Current Research in Biotechnology
ISSN 2590-2628 · Elsevier · Netherlands
Current Research in Biotechnology: CAS Zone 3 · Biology (2025 upgraded edition); impact factor 6.7 (journal website); fully open access; APC about USD 2,950; review about 95 days (submission to acceptance, publisher); 88 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Current Research in Biotechnology is published by Elsevier and is in Zone 3 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Microbial Metabolic Engineering and Bioproduction, Probiotics and Fermented Foods and Biofuel production and bioconversion, together about 19.2% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Current Research in Biotechnology (CRBIOT) is a new primary research, gold open access journal from Elsevier. CRBIOT publishes original papers, reviews, and short communications (including viewpoints and perspectives) resulting from research in biotechnology and biotech-associated disciplines.Current Research in Biotechnology is a peer-reviewed gold open access (OA) journal and upon acceptance all articles are permanently and freely available. It is a companion to the highly regarded review journal Current Opinion in Biotechnology (2018 CiteScore 8.450) and is part of the Current Opinion and Research (CO+RE) suite of journals . All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.Current Research in Biotechnology topics covered include "core" biotechnology disciplines such as genetic and molecular engineering; plant and animal biotechnology; food biotechnology; energy biotechnology; environmental biotechnology; and tissue, cell and pathway engineering. Submissions of manuscripts focused on biotech-associated topics in a broad sense (topics on the interface between technology and biological systems) are also encouraged, including on methods and technology with relevance for biology; molecular medicine, gene therapy, and cellular therapies; drug delivery; bioinformatics, biological big data, in silico modelling, and other computational approaches with a relevance for biology; systems biology and "omics" technologies; wearable technology and other digital health applications; natural products; analytical biotechnology and analytical techniques with applications in biology, bioproduction technologies; approaches and practices with relevance for biotech industry and business; nanobiotechnology and nanomaterials for biological applications; chemical biotechnology; pharmaceutical biotechnology; biomaterials and materials for biological applications; as well as biosensors and bioimaging technology.Current Research in Biotechnology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating impactful and reproducible basic and translational research findings.Expertise - Editors and Editorial Board bring depth and breadth of expertise and experience to the journal.Speed - Submission and peer review is fast, and publication of final manuscripts is instantaneous.Discoverability - Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience.Ethics in Publishing: General Statement The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. For more information, please refer to https://www.elsevier.com/conflictsofinterest
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Biotechnology
Editorial board by country: 9 in mainland China (about 16%); most named Mainland China 9, Austria 8, Germany 7, Italy 6, Spain 6 (57 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Microbial Metabolic Engineering and BioproductionBiochemistry, Genetics and Molecular Biology7.1%
- Probiotics and Fermented FoodsAgricultural and Biological Sciences6.2%
- Biofuel production and bioconversionEngineering5.9%
- Algal biology and biofuel productionEnergy5.9%
- Enzyme Catalysis and ImmobilizationBiochemistry, Genetics and Molecular Biology5.6%
- Advanced biosensing and bioanalysis techniquesBiochemistry, Genetics and Molecular Biology5%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology5%
- Enzyme Production and CharacterizationBiochemistry, Genetics and Molecular Biology4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biotechnology & Applied Microbiology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biotechnology & Applied Microbiology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 6.7Publisher website ·
- CiteScore 2026-06
- 8.6LetPub ·
- CiteScore (publisher) 2018
- 8.45Publisher website ·
- SJR 2026-06
- 1.04LetPub ·
- SNIP 2026-06
- 1.21LetPub ·
- h-index
- 39OpenAlex ·
- i10-index
- 148OpenAlex ·
- 2-year mean citedness
- 6.79OpenAlex ·
- Self-citation rate
- 1.5%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 74LetPub ·
Articles by year OpenAlex count · 411 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 55 | 55 | 26 |
| 2025 | 88 | 88 | 378 |
| 2024 | 93 | 93 | 1,198 |
| 2023 | 53 | 53 | 1,291 |
| 2022 | 51 | 51 | 1,005 |
| 2021 | 40 | 40 | 1,366 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
95 dayssubmission to acceptance · community reports about 14 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 14 weeksLetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- First decision after review
- 46 daysPublisher website ·
- Submission to acceptance
- 95 daysPublisher website ·
- Acceptance to publication
- 8 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,950 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,890 / EUR 2,700 / GBP 2,310 / JPY 358,450 | — | — | |
| LetPub | USD 2,280 | Yes | — | |
| Publisher website | USD 3,320 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers2, by deadline
Publisher websiteWhat to prepare9 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 4,000 words
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted7
- graphical reviewsThe Journal publishes Research Papers, Short Communications, Graphical Reviews and Reviews.Length not stated
- research paperThe Journal publishes Research Papers, Short Communications, Graphical Reviews and Reviews. We support the "Your Paper Your Way" Elsevier guideline which allows…Length not stated
- research papersResearch Papers are not limited in size. However, we do strongly recommend to authors to be as succinct as possible in the best interest of the readers and the …Length not stated
- reviewThe Journal publishes Research Papers, Short Communications, Graphical Reviews and Reviews. We support the "Your Paper Your Way" Elsevier guideline which allows…Length not stated
- reviewsThe Journal publishes Research Papers, Short Communications, Graphical Reviews and Reviews.Length not stated
- short communicationThe Journal publishes Research Papers, Short Communications, Graphical Reviews and Reviews. We support the "Your Paper Your Way" Elsevier guideline which allows…Length not stated
- short communicationsShort Communications have the following soft limits. The manuscript should ideally contain no more than 4-6 Figures/Tables and 4,000 words, including the title …Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Authors must follow Elsevier's Publishing Ethics Policy. Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
Gold open access; articles permanently and freely available upon acceptance. Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized peer review; submissions initially assessed by editors, then typically reviewed by a minimum of two reviewers; editors make the accept/reject decision. Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed per Elsevier's article sharing policy; free preprint posting service on SSRN offered. Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- Netherlands
- Language
- English
- ISSN
- 2590-2628
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Current Research in Biotechnology
What CAS zone is Current Research in Biotechnology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Research in Biotechnology is in Zone 3 of Biology, and in Zone 3 of the minor category Biotechnology & Applied Microbiology. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Research in Biotechnology?
The journal's website gives an impact factor of 6.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 8.6, h-index 39.
How long does peer review take at Current Research in Biotechnology?
The publisher reports about 95 days (submission to acceptance); authors report an average review time of about 14 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Current Research in Biotechnology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 4,000 words; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Current Research in Biotechnology based?
Of the 57 board members whose country the journal's board page names, 9 (about 16%) are in mainland China; the countries named most often are Mainland China (9), Austria (8) and Germany (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Current Research in Biotechnology?
According to LetPub and DOAJ records, Current Research in Biotechnology is indexed in ESCI, Scopus and DOAJ.
Is Current Research in Biotechnology open access, and what is the APC?
Current Research in Biotechnology is a fully open-access journal. APC about USD 2,950.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .